Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fyona Okundia

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Skin Therapy Letter|January 20, 2026
Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque PsoriasisFyona Okundia, Muna Shakhashiro
JAAD Case Reports|October 1, 2025
Compounded metformin 10%/triamcinolone 0.1%/gabapentin 6% for treatment of extragenital lichen sclerosusFyona Okundia, Rachel Branham, Tiffany Mayo
Skin Therapy Letter|May 27, 2026
Exosomes in DermatologyAnnabel Shen, Fyona Okundia, Stephen K Tyring
JAAD Case Reports|March 20, 2026
Xanthogranuloma disseminatum: Successfully treated with statins followed by upadacitinibFyona Okundia, Iman Bouchelkia, Muna Shakhashiro, et al.
Journal of the American Academy of Dermatology|March 15, 2023
Epidemiology of alopecia areata in the Hispanic/Latinx community: A cross-sectional analysis of the All of Us databaseTejas P Joshi, Danielle Garcia, Francesca Gedeon, et al.
International Journal of Dermatology|November 28, 2022
Burden of atopic disease in Black and Hispanic patients with alopecia areata: a case-control study in the All of Us research programTejas P Joshi, Briana Fernandez, Sarah Friske, et al.
Clinical and Experimental Dermatology|March 8, 2023
Association of alopecia areata with alcohol use disorder, attention-deficit hyperactivity disorder and insomnia: a case-control analysis using the All of Us research programmeTejas P Joshi, Harrison Zhu, Miranda Tomaras, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Skin Therapy Letter|January 20, 2026
Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque PsoriasisFyona Okundia, Muna Shakhashiro
JAAD Case Reports|October 1, 2025
Compounded metformin 10%/triamcinolone 0.1%/gabapentin 6% for treatment of extragenital lichen sclerosusFyona Okundia, Rachel Branham, Tiffany Mayo
Skin Therapy Letter|May 27, 2026
Exosomes in DermatologyAnnabel Shen, Fyona Okundia, Stephen K Tyring
JAAD Case Reports|March 20, 2026
Xanthogranuloma disseminatum: Successfully treated with statins followed by upadacitinibFyona Okundia, Iman Bouchelkia, Muna Shakhashiro, et al.
Journal of the American Academy of Dermatology|March 15, 2023
Epidemiology of alopecia areata in the Hispanic/Latinx community: A cross-sectional analysis of the All of Us databaseTejas P Joshi, Danielle Garcia, Francesca Gedeon, et al.
International Journal of Dermatology|November 28, 2022
Burden of atopic disease in Black and Hispanic patients with alopecia areata: a case-control study in the All of Us research programTejas P Joshi, Briana Fernandez, Sarah Friske, et al.
Clinical and Experimental Dermatology|March 8, 2023
Association of alopecia areata with alcohol use disorder, attention-deficit hyperactivity disorder and insomnia: a case-control analysis using the All of Us research programmeTejas P Joshi, Harrison Zhu, Miranda Tomaras, et al.
Pageof 1